Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Postpartum HPV Vaccination with Gardasil 9
NCT03451071Phase 4Completed
- Sponsor
- University of Alabama at Birmingham
- Start
- Apr 2019
- Primary completion
- Jun 2020
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 4 trial of recombinant human papillomavirus 9-valent vaccine in human papillomavirus infection, sponsored by University of Alabama at Birmingham. Started Apr 2019; status: completed.
02
Drugs
recombinant human papillomavirus 9-valent vaccine
03
Conditions
human papillomavirus infection
Beyond the preview
Go deeper on NCT03451071.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03451071.